New Report Available: Philippines Pharmaceuticals & Healthcare Report Q2 2013
Opportunities in the Philippines pharmaceutical and healthcare markets are currently supported by a lack of governance over drug pricing, providing short-term revenue growth opportunities for pharmaceutical firms. Expansion of expenditure is also underpinned by overall economic stability, as well as the eventual implementation of universal healthcare coverage. However, potential threats to political stability may threaten overall growth in the sector in terms of policy continuity.
View full press release